Airiver Medical Achieves FDA IDE Approval for Groundbreaking Respiratory Treatment Trial Airiver Medical has secured FDA IDE approval to begin a pivotal clinical trial for its innovative pulmonary drug-coated balloon aimed at treating benign central airway stenosis.

Airiver Medical Achieves FDA IDE Approval for Groundbreaking Respiratory Treatment Trial #United_States #FDA #Brooklyn_Park #Airiver_Medical #IDE_Approval